Brief: Monopar Therapeutics Says Got Letter From Nasdaq, Co Granted Extension To Aug 26 To Regain Compliance
28/02/2024 19:21
Feb 28 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR THERAPEUTICS- ON FEB 27, GOT LETTER FROM NASDAQ,
CO HAD
BEEN GRANTED ADDITIONAL 180-DAY EXTENSION TO AUG 26 TO REGAIN
COMPLIANCE
Source text for Eikon: ID:n0001437749-24-005871
Further company coverage: MNPR.O
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla